AG
BPMC
Algert Global’s Blueprint Medicines BPMC Stock Holding History
| Quarter | Market Value | Status | Shares |
Shares Change % | Trade Value | Portfolio Weight | Portfolio Position | |
|---|---|---|---|---|---|---|---|---|
|
2025
Q2 | – | Sell |
-68,420
| Closed | -$6.06M | – | 1189 |
|
|
2025
Q1 | $6.06M | Sell |
68,420
-43,752
| -39% | -$3.87M | 0.15% | 214 |
|
|
2024
Q4 | $9.78M | Buy |
112,172
+19,936
| +22% | +$1.74M | 0.23% | 115 |
|
|
2024
Q3 | $8.53M | Buy |
92,236
+26,696
| +41% | +$2.47M | 0.23% | 110 |
|
|
2024
Q2 | $7.06M | Buy |
65,540
+29,330
| +81% | +$3.16M | 0.23% | 109 |
|
|
2024
Q1 | $3.44M | Buy |
36,210
+12,280
| +51% | +$1.16M | 0.13% | 258 |
|
|
2023
Q4 | $2.21M | Buy |
23,930
+17,970
| +302% | +$1.66M | 0.09% | 379 |
|
|
2023
Q3 | $299K | Buy |
+5,960
| New | +$299K | 0.01% | 896 |
|
|
2022
Q3 | – | Sell |
-11,819
| Closed | -$597K | – | 1185 |
|
|
2022
Q2 | $597K | Buy |
11,819
+1,050
| +10% | +$53K | 0.04% | 695 |
|
|
2022
Q1 | $688K | Buy |
10,769
+1,457
| +16% | +$93.1K | 0.05% | 688 |
|
|
2021
Q4 | $997K | Buy |
9,312
+6,394
| +219% | +$685K | 0.12% | 281 |
|
|
2021
Q3 | $300K | Buy |
+2,918
| New | +$300K | 0.04% | 763 |
|
|
2020
Q3 | – | Sell |
-10,813
| Closed | -$843K | – | 407 |
|
|
2020
Q2 | $843K | Sell |
10,813
-14,950
| -58% | -$1.17M | 0.29% | 126 |
|
|
2020
Q1 | $1.51M | Buy |
+25,763
| New | +$1.51M | 0.64% | 23 |
|
|
2018
Q4 | – | Sell |
-5,722
| Closed | -$447K | – | 374 |
|
|
2018
Q3 | $447K | Buy |
+5,722
| New | +$447K | 0.1% | 262 |
|